These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25165491)

  • 1. Evaluation of a
    Petersen H; Nieves W; Russell-Lodrigue K; Roy CJ; Morici LA
    Procedia Vaccinol; 2014 Jan; 8():38-42. PubMed ID: 25165491
    [No Abstract]   [Full Text] [Related]  

  • 2. A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.
    Nieves W; Petersen H; Judy BM; Blumentritt CA; Russell-Lodrigue K; Roy CJ; Torres AG; Morici LA
    Clin Vaccine Immunol; 2014 May; 21(5):747-54. PubMed ID: 24671550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.
    Nieves W; Asakrah S; Qazi O; Brown KA; Kurtz J; Aucoin DP; McLachlan JB; Roy CJ; Morici LA
    Vaccine; 2011 Oct; 29(46):8381-9. PubMed ID: 21871517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Cross Protection against Inhalational Glanders in Mice and Non-Human Primates.
    Baker SM; Davitt CJH; Motyka N; Kikendall NL; Russell-Lodrigue K; Roy CJ; Morici LA
    Vaccines (Basel); 2017 Dec; 5(4):. PubMed ID: 29232837
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis.
    Casey WT; Spink N; Cia F; Collins C; Romano M; Berisio R; Bancroft GJ; McClean S
    Vaccine; 2016 May; 34(23):2616-21. PubMed ID: 27091689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkholderia pseudomallei Δ
    Khakhum N; Bharaj P; Myers JN; Tapia D; Kilgore PB; Ross BN; Walker DH; Endsley JJ; Torres AG
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30602524
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel multi-component vaccine approaches for Burkholderia pseudomallei.
    Morici L; Torres AG; Titball RW
    Clin Exp Immunol; 2019 May; 196(2):178-188. PubMed ID: 30963550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model.
    Trevino SR; Dankmeyer JL; Fetterer DP; Klimko CP; Raymond JLW; Moreau AM; Soffler C; Waag DM; Worsham PL; Amemiya K; Ruiz SI; Cote CK; Krakauer T
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009125. PubMed ID: 33571211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.
    Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW
    Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis.
    Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS
    Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization.
    Nieves W; Heang J; Asakrah S; Höner zu Bentrup K; Roy CJ; Morici LA
    PLoS One; 2010 Dec; 5(12):e14361. PubMed ID: 21179405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combating the great mimicker: latest progress in the development of
    Khakhum N; Chapartegui-González I; Torres AG
    Expert Rev Vaccines; 2020 Jul; 19(7):653-660. PubMed ID: 32669008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of two different vaccine platforms for immunization against melioidosis and glanders.
    Biryukov SS; Cote CK; Klimko CP; Dankmeyer JL; Rill NO; Shoe JL; Hunter M; Shamsuddin Z; Velez I; Hedrick ZM; Rosario-Acevedo R; Talyansky Y; Schmidt LK; Orne CE; Fetterer DP; Burtnick MN; Brett PJ; Welkos SL; DeShazer D
    Front Microbiol; 2022; 13():965518. PubMed ID: 36060742
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.
    Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virulence of the Melioidosis Pathogen Burkholderia pseudomallei Requires the Oxidoreductase Membrane Protein DsbB.
    McMahon RM; Ireland PM; Sarovich DS; Petit G; Jenkins CH; Sarkar-Tyson M; Currie BJ; Martin JL
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29440370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization.
    Elvin SJ; Healey GD; Westwood A; Knight SC; Eyles JE; Williamson ED
    Infect Immun; 2006 Mar; 74(3):1706-11. PubMed ID: 16495542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection.
    Healey GD; Elvin SJ; Morton M; Williamson ED
    Infect Immun; 2005 Sep; 73(9):5945-51. PubMed ID: 16113315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice.
    Su YC; Wan KL; Mohamed R; Nathan S
    Vaccine; 2010 Jul; 28(31):5005-11. PubMed ID: 20546831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.
    Burtnick MN; Heiss C; Roberts RA; Schweizer HP; Azadi P; Brett PJ
    Front Cell Infect Microbiol; 2012; 2():108. PubMed ID: 22912938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
    Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
    PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.